Cypher Metaverse Inc. (BKLLF)

[Palo]

Codebase Investee has secured rights to develop a Transdermal Hydroxychloroquine Drug Delivery System to offer controlled, prescribed dosage mitigating side effects

VANCOUVER, BC / ACCESSWIRE / April 21, 2020 / Codebase Ventures Inc. ("Codebase" or the "Company") (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF), an investment company, is pleased to expand upon its announcement of April 16th regarding its agreement to acquire a 49% interest in an arms-length private company with the rights to a provisional patent for a transdermal drug delivery system for hydroxychloroquine (HCQ) to treat malaria, lupus and rheumatoid arthritis.

https://markets.businessinsider.com/news/stocks/hydroxychloroquine-side-effects-potentially-mitigated-by-transdermal-delivery-1029110862